Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study by Martinelli, E., Cremolini, C., Mazard, T., Vidal, J., Virchow, I., Tougeron, D., Cuyle, P.-J., Chibaudel, B., Kim, S., Ghanem, I., Asselain, B., Castagné, C., Zkik, A., Khan, S., Arnold, D.

Get full text

Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years by Devos, T., Thiessen, S., Cuyle, P. J., Meersseman, W., Delforge, M.

Get full text

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, control... by Eng, Cathy, MD, Kim, Tae Won, MD, Bendell, Johanna, MD, Argilés, Guillem, MD, Tebbutt, Niall C, MD, Di Bartolomeo, Maria, MD, Falcone, Alfredo, MD, Fakih, Marwan, MD, Kozloff, Mark, MD, Segal, Neil H, MD, Sobrero, Alberto, MD, Yan, Yibing, PhD, Chang, Ilsung, PhD, Uyei, Anne, MD, Roberts, Louise, PhD, Ciardiello, Fortunato, MD

Get full text

Real-world first-line treatment of patients with BRAF V600E -mutant metastatic colorectal cancer: the CAPSTAN CRC study by Martinelli, E, Cremolini, C, Mazard, T, Vidal, J, Virchow, I, Tougeron, D, Cuyle, P-J, Chibaudel, B, Kim, S, Ghanem, I, Asselain, B, Castagné, C, Zkik, A, Khan, S, Arnold, D

Get full text

P278 Clinical comparison of eight different calprotectin immunoassays for the diagnosis and follow-up of inflammatory bowel disease by Labaere, D., Smismans, A., Van Olmen, G., Christiaens, P., D'Haens, G., Moons, V., Cuyle, P.-J., Frans, J., Bossuyt, P.

Get full text

Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years by Devos, T, Thiessen, S, Cuyle, P J, Meersseman, W, Delforge, M

Get full text